VCBeat has learned that Shanghai Sipeng Technology Co., Ltd. recently completed a tens-of-millions-of-yuan angel financing round led by Bencao Capital.

SiPeng Technologies is a novel synthetic biology high-tech company dedicated to the advanced manufacturing of bio-based products. Leveraging the profound original expertise in synthetic biology from the State Key Laboratory of Microbial Metabolism at Shanghai Jiao Tong University, the company is committed to building a negative-carbon intelligent manufacturing platform for high-performance bio-based materials. Its product pipeline will encompass proprietary negative-carbon new materials (such as biodegradable plastics synthesized from carbon dioxide via a “one-step” method), polymer monomers, and various high-value compounds.
As an emerging sci-tech enterprise incubated by a prestigious university, Sipeng Technology is progressively establishing a multi-center paradigm: leveraging top-tier universities as innovation sources, cities in the Yangtze River Delta as R&D and innovation hubs, central and western Chinese cities as manufacturing bases, and its Shanghai headquarters as a gateway for global expansion.